Graham Capital Management »

Travere Therapeutics shares owned by Graham Capital Management

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $13M 16M 0.87

More positions owned by Graham Capital Management

Microstrategy Cl A New Put Option (MSTR)
Ishares Tr Russell 2000 Etf (IWM)
Permian Resources Corp Note 3.250% 4/0 (Principal)
Microstrategy Note 2/1 (Principal)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Vaneck Etf Trust Junior Gold Mine Call Option (GDXJ)
Tilray Brands Note 5.200% 6/1 (Principal)
Novavax Note 5.000%12/1 (Principal)
Bloom Energy Corp Note 2.500% 8/1 (Principal)
Penn Entertainment Note 2.750% 5/1 (Principal)
Coinbase Global Note 0.500% 6/0 (Principal)

View all positions for Graham Capital Management

Top funds holding Travere Therapeutics

Wolverine Asset Management
D. E. Shaw & Co
Oaktree Capital Management
Graham Capital Management
Silverback Asset Management
Capstone Investment Advisors
Highbridge Capital Management
CNH Partners
Point72 Asset Management
Lazard Asset Management
Readystate Asset Management
Affinity Asset Advisors
Agf Management
Advent Capital Management
BlackRock

View all funds holding Travere Therapeutics